Citation Impact
Citing Papers
A rare genotype of Cryptococcus gattii caused the cryptococcosis outbreak on Vancouver Island (British Columbia, Canada)
2004
A Golden Bullet? Selective Targeting of Toxoplasma gondii Tachyzoites Using Antibody-Functionalized Gold Nanorods
2007
Phase 1b Study of New Posaconazole Tablet for Prevention of Invasive Fungal Infections in High-Risk Patients with Neutropenia
2014
Clinical Practice Guidelines for the Management of Cryptococcal Disease: 2010 Update by the Infectious Diseases Society of America
2010 Standout
Recent Exposure to Caspofungin or Fluconazole Influences the Epidemiology of Candidemia: a Prospective Multicenter Study Involving 2,441 Patients
2010
Candida Bloodstream Infections: Comparison of Species Distributions and Antifungal Resistance Patterns in Community-Onset and Nosocomial Isolates in the SENTRY Antimicrobial Surveillance Program, 2008-2009
2010
Frequency of Decreased Susceptibility and Resistance to Echinocandins among Fluconazole-Resistant Bloodstream Isolates of Candida glabrata
2012
Epidemiology of Invasive Candidiasis: a Persistent Public Health Problem
2007 Standout
Gram-positive bacteria are a major reservoir of Class 1 antibiotic resistance integrons in poultry litter
2004
Infection Control in the Outpatient Setting
1998
Early Versus Delayed Antiretroviral Therapy and Cerebrospinal Fluid Fungal Clearance in Adults With HIV and Cryptococcal Meningitis
2013 StandoutNobel
Breakthrough invasive fungal disease in patients receiving posaconazole primary prophylaxis: a 4-year study
2014
Leishmaniasis
2018 Standout
Toxoplasmosis
2004 Standout
Impact of Treatment Strategy on Outcomes in Patients with Candidemia and Other Forms of Invasive Candidiasis: A Patient-Level Quantitative Review of Randomized Trials
2012 Standout
Vulvovaginal candidosis
2007 Standout
Cryptococcal Neuroradiological Lesions Correlate with Severity during Cryptococcal Meningoencephalitis in HIV-Positive Patients in the HAART Era
2008
Prophylaxis with Weekly Versus Daily Fluconazole for Fungal Infections in Patients with AIDS
1998
Toxoplasmic Encephalitis in Patients with the Acquired Immunodeficiency Syndrome
1993
Increase inCandida kruseiInfection among Patients with Bone Marrow Transplantation and Neutropenia Treated Prophylactically with Fluconazole
1991 Standout
Protective and Pathological Immunity during Central Nervous System Infections
2017
Guidelines for Preventing Infectious Complications among Hematopoietic Cell Transplantation Recipients: A Global Perspective
2009 Standout
Leishmaniasis in immunosuppressed individuals
2014
Global burden of childhood pneumonia and diarrhoea
2013 Standout
Has the era of individualised medicine arrived for antifungals? A review of antifungal pharmacogenomics
2011
Community-associated meticillin-resistant Staphylococcus aureus
2010
Bacterial Pneumonia in Persons Infected with the Human Immunodeficiency Virus
1995
Inflammatory bowel disease: clinical aspects and established and evolving therapies
2007 Standout
Epidemiology and outcomes of candidemia in 3648 patients: data from the Prospective Antifungal Therapy (PATH Alliance®) registry, 2004–2008
2012
Prospective study of toxoplasma reactivation by polymerase chain reaction in allogeneic stem‐cell transplant recipients
2000
Regulation of hypoxia adaptation: an overlooked virulence attribute of pathogenic fungi?
2010
dsRNA-mediated gene silencing in cultured Drosophila cells: a tissue culture model for the analysis of RNA interference
2000 StandoutNobel
Risk Factors for Voriconazole Hepatotoxicity at 12 Weeks in Lung Transplant Recipients
2012
Acute Infectious Diarrhea
2003
Low Diversity Cryptococcus neoformans Variety grubii Multilocus Sequence Types from Thailand Are Consistent with an Ancestral African Origin
2011
Therapeutic drug monitoring (TDM) of antifungal agents: guidelines from the British Society for Medical Mycology
2013
Antibacterial resistance worldwide: causes, challenges and responses
2004 Standout
Epidemiology of invasive candidiasis
2010
Clinical and Laboratory Markers of Hypersensitivity to Trimethoprim-Sulfamethoxazole in Patients with Pneumocystis carinii Pneumonia and AIDS
1993
Evolution of Antifungal Susceptibility amongCandidaSpecies Isolates Recovered from Human Immunodeficiency Virus–Infected Women Receiving Fluconazole Prophylaxis
2001
NIAID mycoses study group multicenter trial of oral itraconazole therapy for invasive aspergillosis
1994
Cryptococcosis
2006
PKDL and Other Dermal Lesions in HIV Co-infected Patients with Leishmaniasis: Review of Clinical Presentation in Relation to Immune Responses
2014
Risk Factors and Predictors for Candidemia in Pediatric Intensive Care Unit Patients: Implications for Prevention
2010
Understanding variability with voriconazole using a population pharmacokinetic approach: implications for optimal dosing
2014
A Randomized, Double‐Blind, Double‐Dummy, Multicenter Trial of Voriconazole and Fluconazole in the Treatment of Esophageal Candidiasis in Immunocompromised Patients
2001
Prophylaxis against Opportunistic Infections in Patients with Human Immunodeficiency Virus Infection
2000
Epidemiology and Outcomes of Candidemia in 2019 Patients: Data from the Prospective Antifungal Therapy Alliance Registry
2009
The Changing Epidemiology of Cryptococcosis: An Update from Population‐Based Active Surveillance in 2 Large Metropolitan Areas, 1992–2000
2003
Diagnosis, prediction, and natural course of HIV-1 protease-inhibitor-associated lipodystrophy, hyperlipidaemia, and diabetes mellitus: acohort study
1999 Standout
Twelve years of fluconazole in clinical practice: global trends in species distribution and fluconazole susceptibility of bloodstream isolates of Candida
2004
Echinocandin antifungal drugs
2003 Standout
The Impact of the Gut Microbiota on Human Health: An Integrative View
2012 Standout
The Effect of Therapeutic Drug Monitoring on Safety and Efficacy of Voriconazole in Invasive Fungal Infections: A Randomized Controlled Trial
2012
Medication Use and the Risk of Stevens–Johnson Syndrome or Toxic Epidermal Necrolysis
1995 Standout
Diagnosis and Management of Increased Intracranial Pressure in Patients with AIDS and Cryptococcal Meningitis
2000
Hypoxia Rescues Frataxin Loss by Restoring Iron Sulfur Cluster Biogenesis
2019 StandoutNobel
Cryptococcus gattiiInfection: Characteristics and Epidemiology of Cases Identified in a South African Province with High HIV Seroprevalence, 2002–2004
2006
Candida bloodstream infections in intensive care units: Analysis of the extended prevalence of infection in intensive care unit study*
2010
The effect of long-term intermittent trimethoprim/sulfamethoxazole treatment on recurrences of toxoplasmic retinochoroiditis
2002
Visceral Leishmaniasis in Human Immunodeficiency Virus (HIV)-Infected and Non-HIV-Infected Patients
2001
Incidence and risk factors of immune reconstitution inflammatory syndrome complicating HIV-associated cryptococcosis in France
2005
Evolutionary conservation and in vitro reconstitution of microsporidian iron–sulfur cluster biosynthesis
2017
Leishmaniasis, an emerging infection in travelers
2010
Impact on hospital mortality of catheter removal and adequate antifungal therapy in Candida spp. bloodstream infections
2012
Voriconazole: therapeutic review of a new azole antifungal
2004
Radiotherapy plus Concomitant and Adjuvant Temozolomide for Glioblastoma
2005 Standout
Paradoxical Inflammatory Reaction during Treatment of Cryptococcus neoformans var. gattii Meningitis in an HIV-Seronegative Woman
2004
Risk factors and outcomes of Candida krusei bloodstream infection: A matched, case-control study
2012
Determinants of Disease Presentation and Outcome during Cryptococcosis: The CryptoA/D Study
2007
Outcome of Toxoplasma gondii mismatches in heart transplant recipients over a period of 8 years
1994
A Double‐Blind Comparison of Itraconazole Oral Solution and Fluconazole Capsules for the Treatment of Oropharyngeal Candidiasis in Patients with AIDS
1998
Reactive Astrocytes: Production, Function, and Therapeutic Potential
2017 Standout
Repertoires of Autophagy in the Pathogenesis of Ocular Diseases
2015 Standout
Voriconazole pharmacokinetics and exposure–response relationships: Assessing the links between exposure, efficacy and toxicity
2014
The Poor Prognosis of Central Nervous System Cryptococcosis among Nonimmunosuppressed Patients: A Call for Better Disease Recognition and Evaluation of Adjuncts to Antifungal Therapy
2006
Antifungal therapy in invasive fungal infections
2010
A plastid organelle as a drug target in apicomplexan parasites
1997 StandoutNature
Candidemia by Species of the Candida parapsilosis Complex in Children’s Hospital: Prevalence, Biofilm Production and Antifungal Susceptibility
2013
Itraconazole Prophylaxis for Fungal Infections in Patients with Advanced Human Immunodeficiency Virus Infection: Randomized, Placebo‐Controlled, Double‐Blind Study
1999
Candidaemia associated with decreased in vitro fluconazole susceptibility: is Candida speciation predictive of the susceptibility pattern?
2010
Herpes Zoster
2013 Standout
Emerging fungal threats to animal, plant and ecosystem health
2012 StandoutNature
Persisting symptoms and duodenal inflammation related to Giardia duodenalis infection
2007
Mycobacterial Lymphadenitis Associated With the Initiation of Combination Antiretroviral Therapy
1999
Microfluidic diagnostic technologies for global public health
2006 StandoutNature
Gold nanoparticles in biomedical applications: recent advances and perspectives
2011 Standout
Fungal Eye Disease at a Tertiary Care Center: The Utility of Routine Inpatient Consultation
2011
Painful and painless peripheral sensory neuropathies due to HIV infection: a comparison using quantitative sensory evaluation
1999
Protection against Rotavirus Disease after Natural Rotavirus Infection
1994
An Updated Review on Cryptosporidium and Giardia
2006
Rotavirus Infection in Infants as Protection against Subsequent Infections
1996 Standout
Amebiasis
2008
Infection in Organ-Transplant Recipients
1998 Standout
Antibiotic-Associated Diarrhea
2002 Standout
A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitors
1998 Standout
Cryptococcal infection in a cohort of HIV-1-infected Ugandan adults
2002
An Official ATS/IDSA Statement: Diagnosis, Treatment, and Prevention of Nontuberculous Mycobacterial Diseases
2007 Standout
Staphylococcus aureus Infections: Epidemiology, Pathophysiology, Clinical Manifestations, and Management
2015 Standout
Antiamoebic drugs for treating amoebic colitis
2009
Fluorine in Pharmaceutical Industry: Fluorine-Containing Drugs Introduced to the Market in the Last Decade (2001–2011)
2013 Standout
Cryptococcosis in Australasia and the treatment of cryptococcal and other fungal infections with liposomal amphotericin B
2002
Human microsporidial infections
1994 Standout
Candidal Endocarditis Presenting with Bilateral Lower Limb Ischemia
2012
Clinical implications of interferon‐γ genetic and epigenetic variants
2014
Practice Guidelines for the Management of Infectious Diarrhea
2001
Clinical Impact of Cytochrome P450 2C19 Genotype on the Treatment of Invasive Aspergillosis under Routine Therapeutic Drug Monitoring of Voriconazole in a Korean Population
2013
Etiology and evaluation of diarrhea in AIDS:a global perspective at the millennium.
2000
A Plastid of Probable Green Algal Origin in Apicomplexan Parasites
1997 StandoutScience
Guidelines for Preventing Opportunistic Infections among HIV-Infected Persons—2002: Recommendations of the U.S. Public Health Service and the Infectious Diseases Society of America*
2002
Clinical Practice Guideline for the Use of Antimicrobial Agents in Neutropenic Patients with Cancer: 2010 Update by the Infectious Diseases Society of America
2011 Standout
Clinical Practice Guidelines by the Infectious Diseases Society of America for the Treatment of Methicillin-Resistant Staphylococcus aureus Infections in Adults and Children
2011 Standout
Next Generation of Fluorine-Containing Pharmaceuticals, Compounds Currently in Phase II–III Clinical Trials of Major Pharmaceutical Companies: New Structural Trends and Therapeutic Areas
2016 Standout
Synthesis and Electrochemistry of 2-Ethenyl and 2-Ethanyl Derivatives of 5-Nitroimidazole and Antimicrobial Activity against Giardia lamblia
2009 StandoutNobel
Micro-eukaryotic diversity of the human distal gut microbiota: qualitative assessment using culture-dependent and -independent analysis of faeces
2008
Click Chemistry-Facilitated Structural Diversification of Nitrothiazoles, Nitrofurans, and Nitropyrroles Enhances Antimicrobial Activity against Giardia lamblia
2017 StandoutNobel
Fluconazole for the management of invasive candidiasis: where do we stand after 15 years?
2006
Advances in leishmaniasis
2005 Standout
Invasive Candidiasis
2015 Standout
Neuropathic Pain: From Mechanisms to Treatment
2020 Standout
Biotransformation kinetics of pharmaceutical and industrial micropollutants in groundwaters by a laccase cocktail from Pycnoporus sanguineus CS43 fungi
2015
Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America
2016 Standout
Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America
2015 Standout
Role of Sentinel Surveillance of Candidemia: Trends in Species Distribution and Antifungal Susceptibility
2002
In vitro assays elucidate peculiar kinetics of clindamycin action against Toxoplasma gondii
1995
Antifungal Distribution Into Cerebrospinal Fluid, Vitreous Humor, Bone, and Other Difficult Sites
2010
2007 Guideline for Isolation Precautions: Preventing Transmission of Infectious Agents in Health Care Settings
2007 Standout
Multicenter Study of Posaconazole Therapeutic Drug Monitoring: Exposure-Response Relationship and Factors Affecting Concentration
2012
Pharmaceuticals of Emerging Concern in Aquatic Systems: Chemistry, Occurrence, Effects, and Removal Methods
2019 Standout
Fluconazole, a New Antifungal Agent
1990
Prospective, Observational Study of Voriconazole Therapeutic Drug Monitoring among Lung Transplant Recipients Receiving Prophylaxis: Factors Impacting Levels of and Associations between Serum Troughs, Efficacy, and Toxicity
2012
Cryptococcus Infection in Tropical Australia
2004
The Relationship between Leishmaniasis and AIDS: the Second 10 Years
2008
Species differentiation by internally transcribed spacer PCR and HhaI digestion of fluconazole-resistant Candida krusei, Candida inconspicua, and Candida norvegensis strains
1997
Origins and Evolution of Antibiotic Resistance
2010 Standout
Randomized Trial of Trimethoprim-Sulfamethoxazole versus Pyrimethamine-Sulfadiazine for Therapy of Toxoplasmic Encephalitis in Patients with AIDS
1998
Diagnostic Issues, Clinical Characteristics, and Outcomes for Patients with Fungemia
2011
Serum posaconazole levels among haematological cancer patients taking extended release tablets is affected by body weight and diarrhoea: single centre retrospective analysis
2015
Diagnosis and Treatment of Leishmaniasis: Clinical Practice Guidelines by the Infectious Diseases Society of America (IDSA) and the American Society of Tropical Medicine and Hygiene (ASTMH)
2016
Impact of Prior Inappropriate Fluconazole Dosing on Isolation of Fluconazole-Nonsusceptible Candida Species in Hospitalized Patients with Candidemia
2012
Impact of Therapeutic Strategies on the Prognosis of Candidemia in the ICU*
2014
Regulation and Function of T-Cell-Mediated Immunity duringToxoplasma gondiiInfection
1998
Antifungal Susceptibilities among Different Serotypes of Cryptococcus gattii and Cryptococcus neoformans
2008
Adenovirus-Based Expression Vectors and Recombinant Vaccines
1992
Multicenter Study of Voriconazole Pharmacokinetics and Therapeutic Drug Monitoring
2012
Works of Deborah Marriott being referenced
Not Just Little Adults: Candidemia Epidemiology, Molecular Characterization, and Antifungal Susceptibility in Neonatal and Pediatric Patients
2009
Current treatment options for Dientamoeba fragilis infections
2012
Posaconazole Plasma Concentrations in Critically Ill Patients
2011
Low-Dose Trimethoprim-Sulfamethoxazole Prophylaxis for Toxoplasmic Encephalitis in Patients with AIDS
1992
Entamoeba moshkovskii infections in Sydney, Australia
2007
Clinician Ordering Practices for Voriconazole Therapeutic Drug Monitoring: Experiences of a Referral Laboratory
2010
Gastrointestinal Viral Infections in Homosexual Men Who were Symptomatic and Seropositive for Human Immunodeficiency Virus
1988
Irritable bowel syndrome: A review on the role of intestinal protozoa and the importance of their detection and diagnosis
2006
Sulphadiazine desensitization in patients with AIDS and cerebral toxoplasmosis
1991
Disseminated Microsporidiosis Due to Septata intestinalis in Nine Patients Infected with the Human Immunodeficiency Virus: Response to Therapy with Albendazole
1995
Candidemia in nonneutropenic critically ill patients: Risk factors for non-albicans Candida spp.
2008
Active Surveillance of Candidemia, Australia
2006
Nosocomial outbreak of tuberculosis in an outpatient HIV treatment room
1996
Epidemiology and Host- and Variety-Dependent Characteristics of Infection Due to Cryptococcus neoformans in Australia and New Zealand
2000
Treatment of HIV-1-associated microsporidiosis and cryptosporidiosis with combination antiretroviral therapy
1998
Leishmaniasis, an Emerging Imported Infection: Report of 20 Cases From Australia: Table 1
2008
Efficacy of fluconazole in cryptococcal meningitis
1989
Determinants of mortality in non-neutropenic ICU patients with candidaemia
2009
Voriconazole concentrations and outcome of invasive fungal infections
2009
Mycoses in AIDS patients
1994
Seroprevalence of Entamoeba histolytica Infection among Men Who Have Sex with Men in Sydney, Australia
2010
Angiostrongylus cantonensis: a review of its distribution, molecular biology and clinical significance as a human pathogen
2016
Development and ultrastructure ofTrachipleistophora hominisn.g., n.sp. afterin vitroisolation from an AIDS patient and inoculation into athymic mice
1996
Epidemic Strains of Shigella sonnei Biotype g Carrying Integrons
2002
Antifungal Therapy and Management of Complications of Cryptococcosis due to Cryptococcus gattii
2013
Rhizopus microsporus var. rhizopodiformis sinus–orbital zygomycosis in an immunosuppressed patient: successful treatment with posaconazole after a complicated clinical course
2007
Candidaemia with uncommon Candida species: predisposing factors, outcome, antifungal susceptibility, and implications for management
2009
Epidemiology: surveillance of fungal infections
2000
Association between HIV distal symmetric polyneuropathy and Mycobacterium avium complex infection.
1996
Fluconazole once a week as secondary prophylaxis against oropharyngeal candidiasis in HIV‐infected patients: A double‐blind placebo‐controlled study
1993
Microsporidia in the small intestine of HIV‐infected patients: A new diagnostic technique and a new species
1993
Invasive Amebiasis in Men Who Have Sex with Men, Australia
2008
Methicillin-Resistant Staphylococcus aureus (MRSA) Detection: Comparison of Two Molecular Methods (IDI-MRSA PCR Assay and GenoType MRSA Direct PCR Assay) with Three Selective MRSA Agars (MRSA ID, MRSA Select , and CHROMagar MRSA) for Use with Infection-Control Swabs
2007
Posaconazole Exposure-Response Relationship: Evaluating the Utility of Therapeutic Drug Monitoring
2012
Post-Kala-Azar Dermal Leishmaniasis Due to Leishmania infantum in a Human Immunodeficiency Virus Type 1-Infected Patient
2006